Agenda update for our 6th Annual Psychedelic Therapeutics & Drug Development Conference. We’ve just confirmed several timely additions that speak directly to where the field is headed next: How these programs evolve beyond classic mood-disorder models What regulators are focused on right now What it will take to successfully bring psychedelic therapies into real-world clinical care […]